NCT07521930
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Brain Diseases, +42 more
- Locations
-
- Johns Hopkins Medicine Baltimore, Maryland, United States
Clinical trial condition
Amyotrophic Lateral Sclerosis (ALS)
Explore clinical trials studying Amyotrophic Lateral Sclerosis (ALS). Study availability and eligibility vary by location and protocol.
102 public trials
34 recruiting studies
Amyotrophic Lateral Sclerosis (ALS) trial results
Recruiting
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
NCT07023835
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Zydus US015 La Jolla, California, United States
- Zydus US008 Orange, California, United States
- Zydus US013 San Francisco, California, United States
- Zydus US005 New Britain, Connecticut, United States
Recruiting
[18F]ACI-19626 PET in TDP-43 Proteinopathies
NCT06891716
- Conditions
- Alzheimer Disease, Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis, +20 more
- Locations
-
- Amsterdam UMC Amsterdam, Netherlands
Recruiting
Study of COYA 302 for the Treatment of ALS
NCT07161999
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- California Pacific Medical Center San Francisco, California, United States
- Nova Southeastern University Davie, Florida, United States
Recruiting
Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
NCT07257302
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- National Center of Neurology and Psychiatry (NCNP) Kodaira, Tokyo, Japan
Recruiting
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
NCT07726563
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Autoantibody, +11 more
- Locations
-
- National Taiwan University Hospital Taipei City, Taipei, Taiwan
NCT07142291
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Honor Health Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
- University of California San Diego La Jolla, California, United States
- Sutter Health - California Pacific Medical Center Research Institute San Francisco, California, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
NCT06351592
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +10 more
- Locations
-
- Concord Repatriation General Hospital Concord, New South Wales, Australia
- Macquarie University Sydney, New South Wales, Australia
- Sunshine Coast University Hospital Birtinya, Queensland, Australia
- KU Leuven Leuven, Vlaams-Brabant, Belgium
NCT06719947
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Universidade de Brasília - Campus Ceilândia Brasília, Federal District, Brazil
- PneumoCardioVascular Lab - HUOL/UFRN Natal, Rio Grande do Norte, Brazil
- Universidad Autónoma de Chile Santiago, Santiago Metropolitan, Chile
- Universidad do Chile Santiago, Santiago Metropolitan, Chile
Recruiting
Identification of Early Markers for ALS
NCT07213440
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- CHU Tours Tours, France